Regeneron Provides Update on Biologics License Application for Odronextamab

Go back to Regeneron Provides Update on Biologics License Application for Odronextamab
Regeneron (NASDAQ: REGN) Delayed: 762.63 --0 (-0%)
Previous Close $762.63    52 Week High $592.36 
Open $762.63    52 Week Low $325.35 
Day High $762.63    P/E 200.17 
Day Low $762.63    EPS $3.81 
Volume 323